Lessons learned from peginesatide in the treatment of anemia associated with chronic kidney disease in patients on dialysis

Peginesatide is the newest erythropoietin-stimulating agent (ESA) in the quest for the ideal treatment of anemia in chronic kidney disease (CKD) patients. Reduced frequency of administration along with a possibly lower cost as a result of simpler manufacturing techniques compared with other availabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaushik, Tarun, Yaqoob, Muhammad Magdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848525/
https://www.ncbi.nlm.nih.gov/pubmed/24348017
http://dx.doi.org/10.2147/BTT.S34935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848525/
https://www.ncbi.nlm.nih.gov/pubmed/24348017
http://dx.doi.org/10.2147/BTT.S34935

Ejemplares similares